Please type a search term (at least two characters)
11 – 16 May 2019, Montreal, Canada
EMPIR project Innovative measurements for improved diagnosis and management of neurodegenerative diseases (15HLT04, NeuroMet) is developing non-invasive techniques for early diagnosis and monitoring of the progression of diseases such as Alzheimer’s and Parkinson’s. The research is exploring innovative techniques for early diagnosis and monitoring, based on non-invasive magnetic resonance imaging approaches. It is developing improved clinical assessment protocols focused on monitoring declining motor and cognitive functions and increasing behavioural, communicative and psychological symptoms.
Preliminary results were presented at the major 2018 ISMRM conference in Paris, and it is intended that additional results from the project will be presented at the 2019 ISMRM 27th Annual Meeting & Exhibition. The International Society for Magnetic Resonance in Medicine is a professional association dedicated to promoting communication, research, development and application of magnetic resonance techniques in medicine and biology.
For registration and further information visit https://www.ismrm.org/19m/
This EMPIR project is co-funded by the European Union's Horizon 2020 research and innovation programme and the EMPIR Participating States.
Want to hear more about EURAMET?
Sign up for EURAMET newsletters and other information
(You can select which information you would like to receive)
The process for evaluating the 2021 Call for proposals (Stage 2) has been finalised more
EMPIR project outputs contribute to the world’s first international standard in this field more
EURAMET announces the launch of the 2022 Call for Needs, within the European Partnership on Metrology more
Establishing SI linked quantum traceability by exploiting the potential of graphene more
Project is working to develop new test methods for high-frequency interference over electricity grids more